Search details
1.
Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.
Eur J Nucl Med Mol Imaging
; 2024 Apr 08.
Article
in English
| MEDLINE | ID: mdl-38587643
Results
1 -
1
de 1
1
Next >
>>